Curaleaf Clears Competition Reviews for Aurora Cannabis Bid
Curaleaf Holdings announced on November 10, 2026 that it had completed every competition-law review required for its proposed acquisition of Aurora Cannabis after receiving clearances in Germany and Canada. Its enhanced offer for all outstanding Aurora common shares is set to expire on December 4, 2026, unless withdrawn or amended, while the rival Organigram transaction still requires shareholder, court and regulatory approvals. Germany and Canada were the only jurisdictions in which Curaleaf…